Q5IBH6
Gene name |
Spdye4a |
Protein name |
Speedy protein E4A |
Names |
Rapid inducer of G2/M progression in oocytes E4A, RINGO E4A, mSpy/Ringo E4A |
Species |
Mus musculus (Mouse) |
KEGG Pathway |
mmu:74673 |
EC number |
|
Protein Class |
|
Descriptions
The autoinhibited protein was predicted that may have potential autoinhibitory elements via cis-regPred.
Autoinhibitory domains (AIDs)
Target domain |
|
Relief mechanism |
|
Assay |
cis-regPred |
Accessory elements
No accessory elements
Autoinhibited structure
Activated structure
1 structures for Q5IBH6
| Entry ID | Method | Resolution | Chain | Position | Source |
|---|---|---|---|---|---|
| AF-Q5IBH6-F1 | Predicted | AlphaFoldDB |
18 variants for Q5IBH6
| Variant ID(s) | Position | Change | Description | Diseaes Association | Provenance |
|---|---|---|---|---|---|
| rs243798726 | 14 | Q>* | No | EVA | |
| rs3388803261 | 14 | Q>H | No | EVA | |
| rs225191480 | 14 | Q>R | No | EVA | |
| rs3396172292 | 25 | F>V | No | EVA | |
| rs257970896 | 29 | R>G | No | EVA | |
| rs3411667022 | 38 | A>T | No | EVA | |
| rs36850716 | 55 | T>I | No | EVA | |
| rs3388803263 | 57 | P>L | No | EVA | |
| rs583975669 | 93 | S>L | No | EVA | |
| rs226895145 | 94 | L>S | No | EVA | |
| rs1132839570 | 108 | P>L | No | EVA | |
| rs3388808622 | 112 | W>L | No | EVA | |
| rs236569902 | 116 | M>T | No | EVA | |
| rs38810574 | 128 | R>C | No | EVA | |
| rs3388792486 | 149 | V>G | No | EVA | |
| rs3388806994 | 185 | R>M | No | EVA | |
| rs3388795281 | 236 | M>L | No | EVA | |
| rs3388798338 | 244 | R>L | No | EVA |
No associated diseases with Q5IBH6
No regional properties for Q5IBH6
| Type | Name | Position | InterPro Accession |
|---|---|---|---|
| No domain, repeats, and functional sites for Q5IBH6 | |||
1 GO annotations of cellular component
| Name | Definition |
|---|---|
| nucleus | A membrane-bounded organelle of eukaryotic cells in which chromosomes are housed and replicated. In most cells, the nucleus contains all of the cell's chromosomes except the organellar chromosomes, and is the site of RNA synthesis and processing. In some species, or in specialized cell types, RNA metabolism or DNA replication may be absent. |
2 GO annotations of molecular function
| Name | Definition |
|---|---|
| acetylcholine receptor regulator activity | Interacting (directly or indirectly) with acetylcholine receptors such that the proportion of receptors in the active form is changed. |
| protein kinase binding | Binding to a protein kinase, any enzyme that catalyzes the transfer of a phosphate group, usually from ATP, to a protein substrate. |
2 GO annotations of biological process
| Name | Definition |
|---|---|
| cell cycle | The progression of biochemical and morphological phases and events that occur in a cell during successive cell replication or nuclear replication events. Canonically, the cell cycle comprises the replication and segregation of genetic material followed by the division of the cell, but in endocycles or syncytial cells nuclear replication or nuclear division may not be followed by cell division. |
| positive regulation of cyclin-dependent protein serine/threonine kinase activity | Any process that activates or increases the frequency, rate or extent of CDK activity. |
| 10 | 20 | 30 | 40 | 50 | 60 |
| MGEGTPGVDS | ARVQEEGGRD | QSLGFVEGRI | QVGRIVTAGQ | LSLCSEEQSP | QPGITRPSPG |
| 70 | 80 | 90 | 100 | 110 | 120 |
| VVVDGESSGL | AEPRVEATPQ | PPSSIQKRKR | DESLDSEDDL | AELFEPDPQP | VWSVEMLCGL |
| 130 | 140 | 150 | 160 | 170 | 180 |
| RMRLKRRRVS | TVRPEHHKVF | TKLLEDPVVK | KFLTWDKMLR | VSDKYLLSMV | IAYFSRAGLF |
| 190 | 200 | 210 | 220 | 230 | 240 |
| SWQYRPIHFF | LALYLANDME | EDNQAPKQDI | FYFLYGKSYA | QRPMFHKLRF | QFIRSMGWKI |
| 250 | 260 | ||||
| WVSREECEEI | QAYNPDLWVW | ARDRTNLT |